View Author
patient response treatment outcome level study aspergillosi baseline trend therapy disease gmi trends cytokine week 12 analysis antifungal serum cohort data review committee antifungal therapy point infection crp levels 12 weeks galactomannan week 1 erasmus university rotterdam amphotericin b trial value aspergillu survival p fizer result difference signi university nonresponder group responder il -6 antifungal treatment ia patients speci research biomarker il -10 trends -10 voriconazole specimen fi ndings baseline gmi flammatory treatment response ficant cancer cytokine trends figure decrease european organization interleukin death il -6 levels treatment failure ⌬ gmibaseline ¡w 2 weeks week 2 gmibaseline signi ficant review diagnosis rotterdam probability amphotericin cytokine level il -8 protein • chai failure erasmu
2 Most Recent Publications
|
Early Serum Galactomannan Trend as a Predictor of Outcome of
Invasive Aspergillosis
(Article)
Chai, L.Y.A. Kullberg, B.J. Herbrecht, R. Johnson, E.M. Teerenstra, S. Khin, L.W. Maertens, J. Lortholary, O. Donnelly, P.J. Schlamm, H.T. Troke, P.F. |
2012-07-01
|
|
Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive aspergillosis
(Article)
Chai, L.Y.A. Netea, M.G. Teerenstra, S. Earnest, A. Vonk, A.G. Schlamm, H.T. Herbrecht, R. Troke, P.F. Kullberg, B.J. |
2010-11-01
|
